PAPER Jiao S, Li Z
SEARCH RESULTS
331741 RESULTS
PAPER Schon EA, Przedborski S
Mitochondria: the next (neurode)generation.
Neuron. 2011 Jun 23;70(6):1033-53. PubMed: 21689593PAPER Raimondi A, Ferguson SM, Lou X, Armbruster M, Paradise S, Giovedi S, Messa M, Kono N, Takasaki J, Cappello V, O'Toole E, Ryan TA, De Camilli P
Overlapping role of dynamin isoforms in synaptic vesicle endocytosis.
Neuron. 2011 Jun 23;70(6):1100-14. PubMed: 21689597PAPER Han M, Hansmann UH
Replica exchange molecular dynamics of the thermodynamics of fibril growth of Alzheimer's Aβ42 peptide.
J Chem Phys. 2011 Aug 14;135(6):065101. PubMed: 21842950PAPER McDonough RT, Paranjape G, Gallazzi F, Nichols MR
Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
Arch Biochem Biophys. 2011 Oct;514(1-2):27-32. PubMed: 21843498PAPER McMillan LE, Brown JT, Henley JM, Cimarosti H
Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
Neurosci Lett. 2011 Sep 20;502(3):201-8. PubMed: 21843595PAPER Sarkar P, Narayanan J, Harder DR
Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain.
Neuroscience. 2011 Oct 27;194:241-9. PubMed: 21843605PAPER Sheppard O, Plattner F, Rubin A, Slender A, Linehan JM, Brandner S, Tybulewicz VL, Fisher EM, Wiseman FK
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.
Neurobiol Aging. 2011 Aug 13; PubMed: 21843906PAPER Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14330-5. PubMed: 21844361PAPER Ferreri F, Määttä S, Vecchio F, Curcio G, Ferrarelli F
Clinical neurophysiology in Alzheimer's disease.
Int J Alzheimers Dis. 2011;2011:134157. PubMed: 21845216PAPER Dezor M, Dorszewska J, Florczak J, Kempisty B, Jaroszewska-Kolecka J, Rozycka A, Polrolniczak A, Bugaj R, Jagodzinski PP, Kozubski W
Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNF-αlpha proteins in peripheral lymphocytes of patients with Alzheimer's disease.
Folia Neuropathol. 2011;49(2):123-31. PubMed: 21845541PAPER Engedal K, Barca ML, Laks J, Selbaek G
Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria.
Int J Geriatr Psychiatry. 2011 Sep;26(9):944-51. PubMed: 21845597PAPER Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. PubMed: 21845596PAPER Guo X, Wu X, Ren L, Liu G, Li L
Epigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells.
Neuroscience. 2011 Oct 27;194:272-81. PubMed: 21843603PAPER Xiong F, Leonov S, Howard AC, Xiong S, Zhang B, Mei L, McNeil P, Simon S, Xiong WC
Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner.
J Biol Chem. 2011 Oct 7;286(40):35061-70. PubMed: 21844192Current Filters
No filters selected